MBHB Partner Kevin Noonan Quoted in Article Entitled, “MilliporeSigma’s CRISPR Claims Put Pressure On USPTO”

McDonnell Boehnen Hulbert & Berghoff LLP partner¬†Kevin Noonan, Ph.D.¬†is quoted in a July 24, 2019 Law360 article entitled, “MilliporeSigma’s CRISPR Claims Put Pressure On USPTO.” MilliporeSigma is trying to join a conversation about who was the first to invent fundamental technology of the gene-editing tool CRISPR, taking an unusual approach that attorneys say could ramp up pressure on the U.S. Patent and Trademark Office and raise the company’s profile as a player in the space. View the article